Risperidone Sustained Release Microsphere Composition

Patent No. EP3199146 (titled "Risperidone Sustained Release Microsphere Composition") was filed by Nanjing Luye Pharmaceutical on Apr 10, 2012. The application was issued on Jul 17, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALKERMES PHARMA IRELANDApr 17, 2020ATKINS
AERAApr 14, 2020-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3199146

NANJING LUYE PHARMACEUTICAL
Application Number
EP16179390A
Filing Date
Apr 10, 2012
Status
Opposition Rejected
Apr 2, 2022
Publication Date
Jul 17, 2019